4-aminopyridine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peikert, K | 1 |
Naumann, M | 2 |
Günther, R | 1 |
Wegner, F | 2 |
Hermann, A | 2 |
Naujock, M | 1 |
Stanslowsky, N | 1 |
Bufler, S | 1 |
Reinhardt, P | 1 |
Sterneckert, J | 1 |
Kefalakes, E | 1 |
Kassebaum, C | 1 |
Bursch, F | 1 |
Lojewski, X | 1 |
Storch, A | 1 |
Frickenhaus, M | 1 |
Boeckers, TM | 1 |
Putz, S | 1 |
Demestre, M | 1 |
Liebau, S | 1 |
Klingenstein, M | 1 |
Ludolph, AC | 1 |
Dengler, R | 1 |
Kim, KS | 1 |
Petri, S | 1 |
Tovar-y-Romo, LB | 1 |
Tapia, R | 1 |
Aisen, ML | 2 |
Sevilla, D | 2 |
Gibson, G | 1 |
Kutt, H | 1 |
Blau, A | 1 |
Edelstein, L | 2 |
Hatch, J | 1 |
Blass, J | 2 |
Zona, C | 1 |
Ferri, A | 1 |
Gabbianelli, R | 1 |
Mercuri, NB | 1 |
Bernardi, G | 1 |
Rotilio, G | 1 |
Carri, MT | 1 |
1 trial available for 4-aminopyridine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit.
Topics: 4-Aminopyridine; Administration, Oral; Aged; Amifampridine; Amyotrophic Lateral Sclerosis; Cross-Ove | 1996 |
5 other studies available for 4-aminopyridine and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Off-Label Treatment of 4 Amyotrophic Lateral Sclerosis Patients With 4-Aminopyridine.
Topics: 4-Aminopyridine; Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Humans; Male; Off-Label Use; Qu | 2019 |
4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
Topics: 4-Aminopyridine; Amyotrophic Lateral Sclerosis; Caspases; Cell Differentiation; Endoplasmic Reticulu | 2016 |
Cerebral neurons of transgenic ALS mice are vulnerable to glutamate release stimulation but not to increased extracellular glutamate due to transport blockade.
Topics: 4-Aminopyridine; Amyotrophic Lateral Sclerosis; Animals; Biological Transport; Dicarboxylic Acids; D | 2006 |
3,4-diaminopyridine as a treatment for amyotrophic lateral sclerosis.
Topics: 4-Aminopyridine; Affect; Aged; Amifampridine; Amyotrophic Lateral Sclerosis; Cognition; Female; Huma | 1995 |
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS.
Topics: 4-Aminopyridine; Amyotrophic Lateral Sclerosis; Cadmium; Calcium; Electric Stimulation; Humans; Ion | 1998 |